Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
-
* Corresponding author: Dimitrios T Boumpas boumpasd@med.uoc.gr
- † Equal contributors
Arthritis Research & Therapy 2009, 11:R131 doi:10.1186/ar2798
See related editorial by Boumans and Tak, http://arthritis-research.com/content/11/6/134
Evaulated on
Faculty of 1000
Accesses
- Last 30 days: 86 accesses
- Last 365 days: 922 accesses
- All time: 3953 accesses